Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis

This study has been terminated.
(The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.)
Information provided by (Responsible Party):
Albert Christian Ludolph, Prof., University of Ulm Identifier:
First received: June 2, 2008
Last updated: May 28, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):